0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Oncology Treatment Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-12C5642
Home | Market Reports | Health| Health Foundations & Medical Research
Global Oncology Treatment Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Oncology Treatment Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-12C5642
Report
October 2024
Pages:161
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oncology Treatment Drug - Market Size

The global market for Oncology Treatment Drug was estimated to be worth US$ 197440 million in 2023 and is forecast to a readjusted size of US$ 342140 million by 2030 with a CAGR of 8.0% during the forecast period 2024-2030

Oncology Treatment Drug - Market

Oncology Treatment Drug - Market

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology Treatment Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oncology Treatment Drug by region & country, by Type, and by Application.
The Oncology Treatment Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Treatment Drug.
Market Segmentation

Scope of Oncology Treatment Drug - Market Report

Report Metric Details
Report Name Oncology Treatment Drug - Market
Forecasted market size in 2030 US$ 342140 million
CAGR 8.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Others
Segment by Application
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory/Lung Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Oncology Treatment Drug manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Oncology Treatment Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Oncology Treatment Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Oncology Treatment Drug - Market size in 2030?

Ans: The Oncology Treatment Drug - Market size in 2030 will be US$ 342140 million.

Who are the main players in the Oncology Treatment Drug - Market report?

Ans: The main players in the Oncology Treatment Drug - Market are Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences

What are the Application segmentation covered in the Oncology Treatment Drug - Market report?

Ans: The Applications covered in the Oncology Treatment Drug - Market report are Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer, Others

What are the Type segmentation covered in the Oncology Treatment Drug - Market report?

Ans: The Types covered in the Oncology Treatment Drug - Market report are Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy, Others

1 Market Overview
1.1 Oncology Treatment Drug Product Introduction
1.2 Global Oncology Treatment Drug Market Size Forecast
1.3 Oncology Treatment Drug Market Trends & Drivers
1.3.1 Oncology Treatment Drug Industry Trends
1.3.2 Oncology Treatment Drug Market Drivers & Opportunity
1.3.3 Oncology Treatment Drug Market Challenges
1.3.4 Oncology Treatment Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oncology Treatment Drug Players Revenue Ranking (2023)
2.2 Global Oncology Treatment Drug Revenue by Company (2019-2024)
2.3 Key Companies Oncology Treatment Drug Manufacturing Base Distribution and Headquarters
2.4 Key Companies Oncology Treatment Drug Product Offered
2.5 Key Companies Time to Begin Mass Production of Oncology Treatment Drug
2.6 Oncology Treatment Drug Market Competitive Analysis
2.6.1 Oncology Treatment Drug Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Oncology Treatment Drug Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Treatment Drug as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemotherapy
3.1.2 Targeted Therapy
3.1.3 Immunotherapy (Biologic Therapy)
3.1.4 Hormonal Therapy
3.1.5 Others
3.2 Global Oncology Treatment Drug Sales Value by Type
3.2.1 Global Oncology Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oncology Treatment Drug Sales Value, by Type (2019-2030)
3.2.3 Global Oncology Treatment Drug Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Blood Cancer
4.1.2 Breast Cancer
4.1.3 Gastrointestinal Cancer
4.1.4 Prostate Cancer
4.1.5 Respiratory/Lung Cancer
4.1.6 Others
4.2 Global Oncology Treatment Drug Sales Value by Application
4.2.1 Global Oncology Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oncology Treatment Drug Sales Value, by Application (2019-2030)
4.2.3 Global Oncology Treatment Drug Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Oncology Treatment Drug Sales Value by Region
5.1.1 Global Oncology Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oncology Treatment Drug Sales Value by Region (2019-2024)
5.1.3 Global Oncology Treatment Drug Sales Value by Region (2025-2030)
5.1.4 Global Oncology Treatment Drug Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Oncology Treatment Drug Sales Value, 2019-2030
5.2.2 North America Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Oncology Treatment Drug Sales Value, 2019-2030
5.3.2 Europe Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Oncology Treatment Drug Sales Value, 2019-2030
5.4.2 Asia Pacific Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Oncology Treatment Drug Sales Value, 2019-2030
5.5.2 South America Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Oncology Treatment Drug Sales Value, 2019-2030
5.6.2 Middle East & Africa Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oncology Treatment Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oncology Treatment Drug Sales Value
6.3 United States
6.3.1 United States Oncology Treatment Drug Sales Value, 2019-2030
6.3.2 United States Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oncology Treatment Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oncology Treatment Drug Sales Value, 2019-2030
6.4.2 Europe Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oncology Treatment Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oncology Treatment Drug Sales Value, 2019-2030
6.5.2 China Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oncology Treatment Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oncology Treatment Drug Sales Value, 2019-2030
6.6.2 Japan Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oncology Treatment Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oncology Treatment Drug Sales Value, 2019-2030
6.7.2 South Korea Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oncology Treatment Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oncology Treatment Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oncology Treatment Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oncology Treatment Drug Sales Value, 2019-2030
6.9.2 India Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oncology Treatment Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Profile
7.1.2 Roche Main Business
7.1.3 Roche Oncology Treatment Drug Products, Services and Solutions
7.1.4 Roche Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Recent Developments
7.2 Celgene
7.2.1 Celgene Profile
7.2.2 Celgene Main Business
7.2.3 Celgene Oncology Treatment Drug Products, Services and Solutions
7.2.4 Celgene Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.2.5 Celgene Recent Developments
7.3 Novartis
7.3.1 Novartis Profile
7.3.2 Novartis Main Business
7.3.3 Novartis Oncology Treatment Drug Products, Services and Solutions
7.3.4 Novartis Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.3.5 Bristol-Myers Squibb Recent Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Profile
7.4.2 Bristol-Myers Squibb Main Business
7.4.3 Bristol-Myers Squibb Oncology Treatment Drug Products, Services and Solutions
7.4.4 Bristol-Myers Squibb Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.4.5 Bristol-Myers Squibb Recent Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Profile
7.5.2 Johnson & Johnson Main Business
7.5.3 Johnson & Johnson Oncology Treatment Drug Products, Services and Solutions
7.5.4 Johnson & Johnson Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.5.5 Johnson & Johnson Recent Developments
7.6 Merck & Co.
7.6.1 Merck & Co. Profile
7.6.2 Merck & Co. Main Business
7.6.3 Merck & Co. Oncology Treatment Drug Products, Services and Solutions
7.6.4 Merck & Co. Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.6.5 Merck & Co. Recent Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Profile
7.7.2 AstraZeneca Main Business
7.7.3 AstraZeneca Oncology Treatment Drug Products, Services and Solutions
7.7.4 AstraZeneca Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.7.5 AstraZeneca Recent Developments
7.8 Pfizer
7.8.1 Pfizer Profile
7.8.2 Pfizer Main Business
7.8.3 Pfizer Oncology Treatment Drug Products, Services and Solutions
7.8.4 Pfizer Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.8.5 Pfizer Recent Developments
7.9 Amgen
7.9.1 Amgen Profile
7.9.2 Amgen Main Business
7.9.3 Amgen Oncology Treatment Drug Products, Services and Solutions
7.9.4 Amgen Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.9.5 Amgen Recent Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Profile
7.10.2 Eli Lilly Main Business
7.10.3 Eli Lilly Oncology Treatment Drug Products, Services and Solutions
7.10.4 Eli Lilly Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.10.5 Eli Lilly Recent Developments
7.11 AbbVie
7.11.1 AbbVie Profile
7.11.2 AbbVie Main Business
7.11.3 AbbVie Oncology Treatment Drug Products, Services and Solutions
7.11.4 AbbVie Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.11.5 AbbVie Recent Developments
7.12 Takeda
7.12.1 Takeda Profile
7.12.2 Takeda Main Business
7.12.3 Takeda Oncology Treatment Drug Products, Services and Solutions
7.12.4 Takeda Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.12.5 Takeda Recent Developments
7.13 Astellas
7.13.1 Astellas Profile
7.13.2 Astellas Main Business
7.13.3 Astellas Oncology Treatment Drug Products, Services and Solutions
7.13.4 Astellas Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.13.5 Astellas Recent Developments
7.14 Ipsen
7.14.1 Ipsen Profile
7.14.2 Ipsen Main Business
7.14.3 Ipsen Oncology Treatment Drug Products, Services and Solutions
7.14.4 Ipsen Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.14.5 Ipsen Recent Developments
7.15 Sanofi
7.15.1 Sanofi Profile
7.15.2 Sanofi Main Business
7.15.3 Sanofi Oncology Treatment Drug Products, Services and Solutions
7.15.4 Sanofi Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.15.5 Sanofi Recent Developments
7.16 Bayer
7.16.1 Bayer Profile
7.16.2 Bayer Main Business
7.16.3 Bayer Oncology Treatment Drug Products, Services and Solutions
7.16.4 Bayer Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.16.5 Bayer Recent Developments
7.17 Biogen Idec
7.17.1 Biogen Idec Profile
7.17.2 Biogen Idec Main Business
7.17.3 Biogen Idec Oncology Treatment Drug Products, Services and Solutions
7.17.4 Biogen Idec Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.17.5 Biogen Idec Recent Developments
7.18 Teva
7.18.1 Teva Profile
7.18.2 Teva Main Business
7.18.3 Teva Oncology Treatment Drug Products, Services and Solutions
7.18.4 Teva Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.18.5 Teva Recent Developments
7.19 Otsuka
7.19.1 Otsuka Profile
7.19.2 Otsuka Main Business
7.19.3 Otsuka Oncology Treatment Drug Products, Services and Solutions
7.19.4 Otsuka Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.19.5 Otsuka Recent Developments
7.20 Eisai
7.20.1 Eisai Profile
7.20.2 Eisai Main Business
7.20.3 Eisai Oncology Treatment Drug Products, Services and Solutions
7.20.4 Eisai Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.20.5 Eisai Recent Developments
7.21 Merck KGaA
7.21.1 Merck KGaA Profile
7.21.2 Merck KGaA Main Business
7.21.3 Merck KGaA Oncology Treatment Drug Products, Services and Solutions
7.21.4 Merck KGaA Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.21.5 Merck KGaA Recent Developments
7.22 Gilead Sciences
7.22.1 Gilead Sciences Profile
7.22.2 Gilead Sciences Main Business
7.22.3 Gilead Sciences Oncology Treatment Drug Products, Services and Solutions
7.22.4 Gilead Sciences Oncology Treatment Drug Revenue (US$ Million) & (2019-2024)
7.22.5 Gilead Sciences Recent Developments
8 Industry Chain Analysis
8.1 Oncology Treatment Drug Industrial Chain
8.2 Oncology Treatment Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oncology Treatment Drug Sales Model
8.5.2 Sales Channel
8.5.3 Oncology Treatment Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Oncology Treatment Drug Market Trends
    Table 2. Oncology Treatment Drug Market Drivers & Opportunity
    Table 3. Oncology Treatment Drug Market Challenges
    Table 4. Oncology Treatment Drug Market Restraints
    Table 5. Global Oncology Treatment Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Oncology Treatment Drug Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Oncology Treatment Drug Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Oncology Treatment Drug Product Type
    Table 9. Key Companies Time to Begin Mass Production of Oncology Treatment Drug
    Table 10. Global Oncology Treatment Drug Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Treatment Drug as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Oncology Treatment Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Oncology Treatment Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Oncology Treatment Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Oncology Treatment Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Oncology Treatment Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Oncology Treatment Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Oncology Treatment Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Oncology Treatment Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Oncology Treatment Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Oncology Treatment Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Oncology Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Oncology Treatment Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Oncology Treatment Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Oncology Treatment Drug Sales Value by Region (2019-2024) & (%)
    Table 27. Global Oncology Treatment Drug Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Oncology Treatment Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Oncology Treatment Drug Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Oncology Treatment Drug Sales Value, (2025-2030) & (US$ Million)
    Table 31. Roche Basic Information List
    Table 32. Roche Description and Business Overview
    Table 33. Roche Oncology Treatment Drug Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Oncology Treatment Drug Business of Roche (2019-2024)
    Table 35. Roche Recent Developments
    Table 36. Celgene Basic Information List
    Table 37. Celgene Description and Business Overview
    Table 38. Celgene Oncology Treatment Drug Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Oncology Treatment Drug Business of Celgene (2019-2024)
    Table 40. Celgene Recent Developments
    Table 41. Novartis Basic Information List
    Table 42. Novartis Description and Business Overview
    Table 43. Novartis Oncology Treatment Drug Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Oncology Treatment Drug Business of Novartis (2019-2024)
    Table 45. Novartis Recent Developments
    Table 46. Bristol-Myers Squibb Basic Information List
    Table 47. Bristol-Myers Squibb Description and Business Overview
    Table 48. Bristol-Myers Squibb Oncology Treatment Drug Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Oncology Treatment Drug Business of Bristol-Myers Squibb (2019-2024)
    Table 50. Bristol-Myers Squibb Recent Developments
    Table 51. Johnson & Johnson Basic Information List
    Table 52. Johnson & Johnson Description and Business Overview
    Table 53. Johnson & Johnson Oncology Treatment Drug Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Oncology Treatment Drug Business of Johnson & Johnson (2019-2024)
    Table 55. Johnson & Johnson Recent Developments
    Table 56. Merck & Co. Basic Information List
    Table 57. Merck & Co. Description and Business Overview
    Table 58. Merck & Co. Oncology Treatment Drug Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Oncology Treatment Drug Business of Merck & Co. (2019-2024)
    Table 60. Merck & Co. Recent Developments
    Table 61. AstraZeneca Basic Information List
    Table 62. AstraZeneca Description and Business Overview
    Table 63. AstraZeneca Oncology Treatment Drug Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Oncology Treatment Drug Business of AstraZeneca (2019-2024)
    Table 65. AstraZeneca Recent Developments
    Table 66. Pfizer Basic Information List
    Table 67. Pfizer Description and Business Overview
    Table 68. Pfizer Oncology Treatment Drug Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Oncology Treatment Drug Business of Pfizer (2019-2024)
    Table 70. Pfizer Recent Developments
    Table 71. Amgen Basic Information List
    Table 72. Amgen Description and Business Overview
    Table 73. Amgen Oncology Treatment Drug Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Oncology Treatment Drug Business of Amgen (2019-2024)
    Table 75. Amgen Recent Developments
    Table 76. Eli Lilly Basic Information List
    Table 77. Eli Lilly Description and Business Overview
    Table 78. Eli Lilly Oncology Treatment Drug Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Oncology Treatment Drug Business of Eli Lilly (2019-2024)
    Table 80. Eli Lilly Recent Developments
    Table 81. AbbVie Basic Information List
    Table 82. AbbVie Description and Business Overview
    Table 83. AbbVie Oncology Treatment Drug Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Oncology Treatment Drug Business of AbbVie (2019-2024)
    Table 85. AbbVie Recent Developments
    Table 86. Takeda Basic Information List
    Table 87. Takeda Description and Business Overview
    Table 88. Takeda Oncology Treatment Drug Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Oncology Treatment Drug Business of Takeda (2019-2024)
    Table 90. Takeda Recent Developments
    Table 91. Astellas Basic Information List
    Table 92. Astellas Description and Business Overview
    Table 93. Astellas Oncology Treatment Drug Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Oncology Treatment Drug Business of Astellas (2019-2024)
    Table 95. Astellas Recent Developments
    Table 96. Ipsen Basic Information List
    Table 97. Ipsen Description and Business Overview
    Table 98. Ipsen Oncology Treatment Drug Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Oncology Treatment Drug Business of Ipsen (2019-2024)
    Table 100. Ipsen Recent Developments
    Table 101. Sanofi Basic Information List
    Table 102. Sanofi Description and Business Overview
    Table 103. Sanofi Oncology Treatment Drug Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Oncology Treatment Drug Business of Sanofi (2019-2024)
    Table 105. Sanofi Recent Developments
    Table 106. Bayer Basic Information List
    Table 107. Bayer Description and Business Overview
    Table 108. Bayer Oncology Treatment Drug Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Oncology Treatment Drug Business of Bayer (2019-2024)
    Table 110. Bayer Recent Developments
    Table 111. Biogen Idec Basic Information List
    Table 112. Biogen Idec Description and Business Overview
    Table 113. Biogen Idec Oncology Treatment Drug Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Oncology Treatment Drug Business of Biogen Idec (2019-2024)
    Table 115. Biogen Idec Recent Developments
    Table 116. Teva Basic Information List
    Table 117. Teva Description and Business Overview
    Table 118. Teva Oncology Treatment Drug Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Oncology Treatment Drug Business of Teva (2019-2024)
    Table 120. Teva Recent Developments
    Table 121. Otsuka Basic Information List
    Table 122. Otsuka Description and Business Overview
    Table 123. Otsuka Oncology Treatment Drug Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Oncology Treatment Drug Business of Otsuka (2019-2024)
    Table 125. Otsuka Recent Developments
    Table 126. Eisai Basic Information List
    Table 127. Eisai Description and Business Overview
    Table 128. Eisai Oncology Treatment Drug Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Oncology Treatment Drug Business of Eisai (2019-2024)
    Table 130. Eisai Recent Developments
    Table 131. Merck KGaA Basic Information List
    Table 132. Merck KGaA Description and Business Overview
    Table 133. Merck KGaA Oncology Treatment Drug Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Oncology Treatment Drug Business of Merck KGaA (2019-2024)
    Table 135. Merck KGaA Recent Developments
    Table 136. Gilead Sciences Basic Information List
    Table 137. Gilead Sciences Description and Business Overview
    Table 138. Gilead Sciences Oncology Treatment Drug Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Oncology Treatment Drug Business of Gilead Sciences (2019-2024)
    Table 140. Gilead Sciences Recent Developments
    Table 141. Key Raw Materials Lists
    Table 142. Raw Materials Key Suppliers Lists
    Table 143. Oncology Treatment Drug Downstream Customers
    Table 144. Oncology Treatment Drug Distributors List
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
    Table 148. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Oncology Treatment Drug Product Picture
    Figure 2. Global Oncology Treatment Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Oncology Treatment Drug Report Years Considered
    Figure 5. Global Oncology Treatment Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology Treatment Drug Revenue in 2023
    Figure 7. Oncology Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Chemotherapy Picture
    Figure 9. Targeted Therapy Picture
    Figure 10. Immunotherapy (Biologic Therapy) Picture
    Figure 11. Hormonal Therapy Picture
    Figure 12. Others Picture
    Figure 13. Global Oncology Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Oncology Treatment Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Blood Cancer
    Figure 16. Product Picture of Breast Cancer
    Figure 17. Product Picture of Gastrointestinal Cancer
    Figure 18. Product Picture of Prostate Cancer
    Figure 19. Product Picture of Respiratory/Lung Cancer
    Figure 20. Product Picture of Others
    Figure 21. Global Oncology Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Oncology Treatment Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 23. North America Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 24. North America Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
    Figure 25. Europe Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 26. Europe Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
    Figure 27. Asia Pacific Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 28. Asia Pacific Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
    Figure 29. South America Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 30. South America Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
    Figure 31. Middle East & Africa Oncology Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 32. Middle East & Africa Oncology Treatment Drug Sales Value by Country (%), 2023 VS 2030
    Figure 33. Key Countries/Regions Oncology Treatment Drug Sales Value (%), (2019-2030)
    Figure 34. United States Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 35. United States Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 36. United States Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 37. Europe Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Europe Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 39. Europe Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 40. China Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 41. China Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 42. China Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 43. Japan Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Japan Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 45. Japan Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 46. South Korea Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 47. South Korea Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 48. South Korea Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 49. Southeast Asia Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Southeast Asia Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 51. Southeast Asia Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 52. India Oncology Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 53. India Oncology Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 54. India Oncology Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 55. Oncology Treatment Drug Industrial Chain
    Figure 56. Oncology Treatment Drug Manufacturing Cost Structure
    Figure 57. Channels of Distribution (Direct Sales, and Distribution)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS